ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: Wuxi PharmaTech (Cayman) Inc. Sponsored ADR (WX) Report Updated: Dec 15, 2014 | Print This Page

Get more stock ratings by Louis Navellier

Wuxi PharmaTech (Cayman) Inc. Sponsored ADR (WX)

Rating: Hold Volatility: Moderate
Total Grade: C Industry: Life Sciences Tools & Services
Competitors: ICLR, ILMN, SQNM, NEO

Stock Analysis

Rating: Monthly View

A
B
C
D
F
December January February March April May June July August September October November

Rating: Weekly View

This Week: C down no change
Last Week: C same no change
Two Weeks Ago: C up no change
service keys

Wuxi PharmaTech (Cayman) Inc. Sponsored ADR© quotemedia

Company Profile

Wuxi PharmaTech (Cayman) Inc., through its subsidiaries, operates as a pharmaceutical, biotechnology, and medical device research and development outsourcing company primarily in the People’s Republic of China and the United States. It operates in two segments, Laboratory Services and Manufacturing Services. The Laboratory Services segment offers synthetic chemistry, discovery biology, medicinal and analytical chemistry, DMPK/ADME, formulation process chemistry, cell line and bioprocess development, toxicology, safety pharmacology, clinical development, bioanalytical services, genomics, and research reagent production services for pharmaceutical, biotechnology, and medical device companies, as well as testing services for biologics, medical devices, and combination products. The Manufacturing Services segment engages in the production of manufacturing advanced intermediates and active pharmaceutical ingredients for use by pharmaceutical companies in preclinical and clinical trials of small-molecule products; and advanced intermediates that are used as ingredients in small-molecule commercial products. The company sells its products directly to pharmaceutical, biotechnology, and medical device companies. Wuxi PharmaTech (Cayman) Inc. was founded in 2000 and is headquartered in Shanghai, the People’s Republic of China.

Recent News: Wuxi PharmaTech (Cayman) Inc. Sponsored ADR